Neuropace shares owned by Citigroup
Historical chart of Citigroup investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Neuropace by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $14k | 1.0k | 13.15 |
| 2025-03-31 | $124k | 10k | 12.29 |
| 2024-12-31 | $124k | 11k | 11.19 |
| 2024-09-30 | $69k | 9.8k | 6.97 |
| 2024-06-30 | $22k | 3.0k | 7.56 |
| 2024-03-31 | $999k | 76k | 13.20 |
| 2023-12-31 | $361k | 35k | 10.31 |
| 2023-09-30 | $29k | 3.0k | 9.73 |
| 2021-12-31 | $19k | 1.8k | 10.33 |